Skip to main content
Premium Trial:

Request an Annual Quote

Olink Proteomics Explore 1536 Assay

Sweden's Olink Proteomics has launched the Olink Explore 1536, a multiplex, proximity-extension immunoassay with next-generation sequencing readout on the Illumina NovaSeq platform. The semi-automated assay can measure more than 1,460 human proteins from less than 3 microliters of plasma or serum, enabling more than 1.35 million protein measurements per week per NGS system. These curated proteins provide coverage of the low-abundance plasma proteome. Olink is offering the assay as a service performed at the firm's labs in Sweden and Boston.

The Scan

Another Resignation

According to the Wall Street Journal, a third advisory panel member has resigned following the US Food and Drug Administration's approval of an Alzheimer's disease drug.

Novavax Finds Its Vaccine Effective

Reuters reports Novavax's SARS-CoV-2 vaccine is more than 90 percent effective in preventing COVID-19.

Can't Be Used

The US Food and Drug Administration says millions of vaccine doses made at an embattled manufacturing facility cannot be used, the New York Times reports.

PLOS Papers on Frozen Shoulder GWAS, Epstein-Barr Effects on Immune Cell Epigenetics, More

In PLOS this week: genome-wide association study of frozen shoulder, epigenetic patterns of Epstein-Barr-infected B lymphocyte cells, and more.